We are live on ! Find out more
CTIC

CTI BioPharma Corp. (DE) Common Stock
CTIC

Delisted

CTIC was delisted on the 23rd of June, 2023.

Back to rankings

86 hedge funds and large institutions have $78.9M invested in CTI BioPharma Corp. (DE) Common Stock in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 31 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

507% more call options, than puts

Call options by funds: $1.74M | Put options by funds: $286K

9% less funds holding

Funds holding: 95 → 86 (-9)

18% less capital invested

Capital invested by funds: $96.6M → $78.9M (-$17.7M)

35% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 31

53% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 17

Holders
86
Holders Change
-9
Holders Change %
-9.47%
% of All Funds
2.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
20
Reduced
31
Closed
17
Calls
$1.74M
Puts
$286K
Net Calls
+$1.45M
Net Calls Change
-$643K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$17.3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.44M
3
CCM
Consonance Capital Management
New York
+$795K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$566K
5
Barclays
Barclays
United Kingdom
+$305K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$2.87M
2
LOAMU
Lombard Odier Asset Management (USA)
New York
-$2.53M
3
OAM
Oxford Asset Management
United Kingdom
-$2.08M
4
PCM
Pyrrho Capital Management
New York
-$1.19M
5
Renaissance Technologies
Renaissance Technologies
New York
-$1.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
Swiss National Bank
26
Swiss National Bank
Switzerland
$370K +$47.7K +2,760 +12%
Jane Street
27
Jane Street
New York
$289K -$2.87M -166,288 -89%
Charles Schwab
28
Charles Schwab
California
$279K – – –
ARTA
29
A.R.T. Advisors
New York
$243K – – –
AllianceBernstein
30
AllianceBernstein
Tennessee
$229K – – –
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$220K -$42.5K -2,460 -14%
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$213K +$9.11K +527 +4%
Barclays
33
Barclays
United Kingdom
$189K +$305K +17,635 +1,375%
NFA
34
Nationwide Fund Advisors
Ohio
$158K – – –
BA
35
BlackRock Advisors
Delaware
$156K -$8.14K -471 -4%
VKH
36
Virtu KCG Holdings
New York
$155K -$397K -22,966 -68%
MLICM
37
Metropolitan Life Insurance Company (MetLife)
New York
$152K +$67.7K +3,919 +60%
VOYA Investment Management
38
VOYA Investment Management
Georgia
$148K – – –
CS
39
Credit Suisse
Switzerland
$143K -$31K -1,794 -15%
AIG
40
American International Group
New York
$142K -$242 -14 -0.1%
PAM
41
Panagora Asset Management
Massachusetts
$139K +$166K +9,583 New
UBS AM
42
UBS AM
Illinois
$138K – – –
AQR Capital Management
43
AQR Capital Management
Connecticut
$118K -$67.2K -3,890 -33%
Wells Fargo
44
Wells Fargo
California
$115K -$19K -1,102 -12%
FHC
45
First Heartland Consultants
Missouri
$109K – – –
BCM
46
Bridgeway Capital Management
Texas
$107K – – –
Morgan Stanley
47
Morgan Stanley
New York
$88K -$7.46K -432 -7%
JAM
48
JW Asset Management
Florida
$76K – – –
Jacobs Levy Equity Management
49
Jacobs Levy Equity Management
New Jersey
$68K -$176K -10,210 -69%
GC
50
Guggenheim Capital
Illinois
$59K -$3.32K -192 -5%
1
2
3 4

CTIC Hedge Fund Activity: Q3 2015 in Review

86 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in CTI BioPharma Corp. (DE) Common Stock (CTIC) for Q3 2015, worth a combined $78.9M — down 18% from $96.6M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CTIC and 8 opened new positions — a net loss of 9 holders — while 31 trimmed existing stakes and 20 added.

The largest buyer was BVF Inc, opening a new position worth an estimated $17.3M. The largest seller was Jane Street, cutting an estimated $2.87M.

  • 86 institutional investors held CTI BioPharma Corp. (DE) Common Stock (CTIC) as of Q3 2015, down from 95 in Q2 2015.
  • Funds reported $78.9M of CTI BioPharma Corp. (DE) Common Stock stock for Q3 2015, down 18% quarter-over-quarter.
  • 8 funds opened new CTI BioPharma Corp. (DE) Common Stock positions in Q3 2015 and 17 closed out, a net change of -9 holders.
  • The largest CTI BioPharma Corp. (DE) Common Stock buyer in Q3 2015 was BVF Inc, an estimated $17.3M added.
  • The largest CTI BioPharma Corp. (DE) Common Stock seller in Q3 2015 was Jane Street, an estimated $2.87M sold.

Based on aggregated 13F filings for Q3 2015.